JP2023550355A5 - - Google Patents
Info
- Publication number
- JP2023550355A5 JP2023550355A5 JP2023528758A JP2023528758A JP2023550355A5 JP 2023550355 A5 JP2023550355 A5 JP 2023550355A5 JP 2023528758 A JP2023528758 A JP 2023528758A JP 2023528758 A JP2023528758 A JP 2023528758A JP 2023550355 A5 JP2023550355 A5 JP 2023550355A5
- Authority
- JP
- Japan
- Prior art keywords
- lymphocytes
- genetically modified
- lineage
- cell surface
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113739P | 2020-11-13 | 2020-11-13 | |
| US63/113,739 | 2020-11-13 | ||
| US202163229017P | 2021-08-03 | 2021-08-03 | |
| US63/229,017 | 2021-08-03 | ||
| PCT/US2021/059182 WO2022104090A1 (en) | 2020-11-13 | 2021-11-12 | Methods and compositions relating to genetically engineered cells expressing chimeric antigen receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550355A JP2023550355A (ja) | 2023-12-01 |
| JP2023550355A5 true JP2023550355A5 (cg-RX-API-DMAC7.html) | 2024-11-21 |
Family
ID=79602283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528758A Pending JP2023550355A (ja) | 2020-11-13 | 2021-11-12 | キメラ抗原受容体を発現する遺伝子操作された細胞に関連する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230414755A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4243858A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023550355A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230107610A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021380830A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3201003A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022104090A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250026552A (ko) | 2023-08-17 | 2025-02-25 | 현대모비스 주식회사 | 팝업 디스플레이 장치 및 이를 장착한 차량 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4694778A (en) | 1984-05-04 | 1987-09-22 | Anicon, Inc. | Chemical vapor deposition wafer boat |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JPS6412935A (en) | 1987-07-02 | 1989-01-17 | Mitsubishi Electric Corp | Constant-speed travel device for vehicle |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| EP3129485B2 (en) | 2014-04-09 | 2022-12-21 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating cystic fibrosis |
| CA2969619A1 (en) | 2014-12-03 | 2016-06-09 | Agilent Technologies, Inc. | Guide rna with chemical modifications |
| CN107787367B (zh) | 2015-04-06 | 2021-10-26 | 里兰斯坦福初级大学理事会 | 用于crispr/cas介导的基因调控的化学修饰的引导rna |
| IL258491B2 (en) * | 2015-10-16 | 2023-09-01 | Univ Columbia | Preparations and methods for inhibiting antigens of a particular lineage |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US10767175B2 (en) | 2016-06-08 | 2020-09-08 | Agilent Technologies, Inc. | High specificity genome editing using chemically modified guide RNAs |
| CN110249052B (zh) | 2016-12-30 | 2024-04-12 | 爱迪塔斯医药公司 | 合成的指导分子、组合物和与其相关的方法 |
| KR102709603B1 (ko) * | 2017-02-28 | 2024-09-27 | 보르 바이오파마 인크. | 계통 특이적 단백질의 억제를 위한 조성물 및 방법 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| CA3110837A1 (en) | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
-
2021
- 2021-11-12 WO PCT/US2021/059182 patent/WO2022104090A1/en not_active Ceased
- 2021-11-12 AU AU2021380830A patent/AU2021380830A1/en not_active Abandoned
- 2021-11-12 US US18/036,698 patent/US20230414755A1/en active Pending
- 2021-11-12 EP EP21843800.0A patent/EP4243858A1/en not_active Withdrawn
- 2021-11-12 JP JP2023528758A patent/JP2023550355A/ja active Pending
- 2021-11-12 CA CA3201003A patent/CA3201003A1/en active Pending
- 2021-11-12 KR KR1020237019126A patent/KR20230107610A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marcu et al. | 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains | |
| Förster et al. | Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. | |
| EP3653049B1 (en) | Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same | |
| Kaushik et al. | Murine V kappa gene expression does not follow the VH paradigm. | |
| Fok et al. | The lncRNA connection between cellular metabolism and epigenetics in trained immunity | |
| JP2023055884A5 (cg-RX-API-DMAC7.html) | ||
| JP2018531260A5 (cg-RX-API-DMAC7.html) | ||
| CN104334732B (zh) | 表达人λ免疫球蛋白轻链可变结构域的动物 | |
| JP2022520138A5 (cg-RX-API-DMAC7.html) | ||
| JP2019531743A5 (cg-RX-API-DMAC7.html) | ||
| JP2024528202A5 (cg-RX-API-DMAC7.html) | ||
| JP2022521787A5 (cg-RX-API-DMAC7.html) | ||
| Bascuas et al. | Salmonella immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing mice | |
| US20240373832A1 (en) | Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci | |
| JP2022534813A5 (cg-RX-API-DMAC7.html) | ||
| JP2022526646A5 (cg-RX-API-DMAC7.html) | ||
| JP2022554348A5 (cg-RX-API-DMAC7.html) | ||
| Bhat et al. | Contemplating dichotomous nature of gamma delta T cells for immunotherapy | |
| Pickel et al. | Differential regulation of V (D) J recombination during development of avian B and T cells | |
| Meeuwsen | B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice I. Preferential utilization of the CH-proximal VH gene family PC7183 | |
| JP2026035762A5 (cg-RX-API-DMAC7.html) | ||
| Kabelitz et al. | Epigenetics of the immune system | |
| Hamad et al. | T cell progenitors in the murine small intestine | |
| EP3484284A1 (en) | Animals, cells, ligands, polypeptides & methods | |
| JPWO2022065444A5 (cg-RX-API-DMAC7.html) |